Briva Oral Solution 50 mg/5 ml contains Brivaracetam, an antiepileptic drug used for the management of seizure disorders. This oral liquid formulation is designed to provide accurate dosing and ease of administration, especially for pediatric patients, elderly individuals, and patients who have difficulty swallowing tablets. Briva Oral Solution is commonly used as adjunctive therapy in the treatment of partial-onset seizures and helps achieve better seizure control with good tolerability.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each 5 ml of oral solution contains:
Brivaracetam 50 mg
Antiepileptic agent
Central nervous system (CNS) active drug
Brivaracetam is a high-affinity ligand for synaptic vesicle protein 2A (SV2A), a protein involved in neurotransmitter release in the brain. By selectively binding to SV2A, brivaracetam modulates synaptic transmission and stabilizes neuronal activity. This action helps reduce excessive and abnormal electrical discharges in the brain that lead to seizures.
Compared to some other antiepileptic drugs, brivaracetam has a rapid onset of action and predictable pharmacokinetics. It shows linear absorption and does not significantly interact with most commonly used medications. Its targeted mechanism allows effective seizure control with a lower risk of cognitive impairment and behavioral side effects.
Briva Oral Solution is indicated for:
Treatment of partial-onset (focal) seizures
Use as adjunctive therapy in patients with epilepsy
Seizure management in adults, adolescents, and children as prescribed by a physician
Briva Oral Solution is administered orally and the dose should be individualized according to the patient’s age, body weight, and clinical response. It is usually taken twice daily, with or without food, as directed by a healthcare professional.
The solution should be measured carefully using a calibrated measuring device to ensure accurate dosing. Treatment should not be stopped abruptly without medical advice, as sudden discontinuation may increase seizure frequency.
Effective control of partial-onset seizures
Oral liquid formulation ensures dosing flexibility
Rapid onset and consistent therapeutic effect
Favorable safety and tolerability profile
Minimal drug–drug interactions compared to many antiepileptic agents
Use with caution in patients with liver impairment; dose adjustment may be required
Monitor for changes in mood, behavior, or signs of depression
Avoid alcohol consumption, as it may enhance CNS-related side effects
Not recommended to discontinue treatment abruptly
Use during pregnancy and breastfeeding only if the potential benefit justifies the potential risk
Store below 30°C in a dry place. Protect from light. Keep the bottle tightly closed and out of reach of children. Shake well before use.
Login Or Registerto submit your questions to seller
No none asked to seller yet